Top Markets
Coin of the day
Nuformix plc Nuformix plc

Nuformix plc

NFX
Classement en actions #20651
Nuformix plc operates in the field of pharmaceutical development for treating... Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc was founded in 2008 and is based in London, the United Kingdom.
Prix de l'action
$0.00244926
Capitalisation boursière
$51.67K
Changement (1 jour)
5.88%
Changement (1 an)
110.15%
Pays
GB
Échange Nuformix plc (NFX)

Catégorie

Historique du prix de l'action pour Nuformix plc (NFX)
Prix de clôture le plus élevé : $0.00 le 2026-03-01

Prix de clôture le plus bas : $0.04 le 2015-12-01
Historique du prix de l'action de Nuformix plc de 2015 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 0.00%
2025 411.32%
2024 -82.51%
2023 -11.70%
2022 -74.73%
2021 -56.41%
2020 -60.57%
2019 249.10%
2018 -26.41%
2017 -13.50%
2016 17.74%
2015 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$36.04 -48.63%
DK
$433.07 -13.83%
US
$737.71 16.02%
US
$298.91 66.79%
BE
$100.99 -36.10%
AU